Bill

Bill > SB682


MD SB682

MD SB682
Maryland Medical Assistance Program - Gender-Affirming Treatment (Trans Health Equity Act of 2022)


summary

Introduced
02/04/2022
In Committee
03/21/2022
Crossed Over
03/21/2022
Passed
Dead
04/11/2022

Introduced Session

2022 Regular Session

Bill Summary

Requiring, beginning on January 1, 2023, the Maryland Medical Assistance Program to provide gender-affirming treatment; and prohibiting the Program from issuing an adverse benefit determination related to gender-affirming treatment unless a health care provider with experience prescribing or delivering gender-affirming treatment has reviewed and confirmed the appropriateness of the determination.

AI Summary

This bill, the Trans Health Equity Act of 2022, requires the Maryland Medical Assistance Program to provide gender-affirming treatment starting January 1, 2023. Gender-affirming treatment includes various medically necessary procedures such as hormone therapy, hair alteration, voice modification, and surgical procedures to align an individual's appearance or physical body with their gender identity. The bill prohibits the Program from denying or limiting coverage for gender-affirming treatment that is prescribed according to current clinical standards of care and medically necessary, regardless of the individual's gender identity. The bill also requires managed care organizations and the Department of Health to report on and publish information about providers offering gender-affirming treatment to ensure access across the state.

Committee Categories

Budget and Finance, Health and Social Services

Sponsors (13)

Last Action

House Health and Government Operations Hearing (13:30 3/24/2022 ) (on 03/24/2022)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...